Candidiasis, Invasive Completed Phase 2 Trials for Caspofungin (DB00520)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

DBCOND0036184 (Candidiasis, Invasive)Completed2 IdentifierTitlePurposeDrugs
NCT01165320A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)Treatment
NCT02734862CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionTreatment